The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidence
- 9 February 2016
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 247, 87-96
- https://doi.org/10.1016/j.atherosclerosis.2016.02.002
Abstract
No abstract availableKeywords
Funding Information
- Irish Endocrine Society Small Grant Scheme
- DCU O’Hare Scholarship
- Government of Ireland/Irish Research Council Postgraduate Scholarship (GOIPG/2015/3758)
This publication has 90 references indexed in Scilit:
- Following TRAIL’s path in the immune systemImmunology, 2009
- The Puzzling Role of TRAIL in Endothelial Cell BiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- TRAIL signalling: Decisions between life and deathThe International Journal of Biochemistry & Cell Biology, 2007
- The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biologyCytokine & Growth Factor Reviews, 2006
- Expression of TRAIL and TRAIL receptors in normal and malignant tissuesCell Research, 2005
- Tissue distribution of the death ligand TRAIL and its receptors.Journal of Histochemistry & Cytochemistry, 2004
- TRAIL expression in vascular smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
- To die or not to die—the quest of the TRAIL receptorsJournal of Leukocyte Biology, 1999
- Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAILJournal of Biological Chemistry, 1998
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995